Introduction
============

Gene duplication is a rare event in eukaryotic genomes and has been suggested to be the major source of novel genetic material ([@evu166-B52]). Estimates of the rate of gene duplication in vertebrates vary from 1 gene per 100 to 1 gene per 1,000 per million years ([@evu166-B44], [@evu166-B45]; [@evu166-B7]), and the most common fate for a duplicate gene is the loss of its function (nonfunctionalization, pseudogenization \[[@evu166-B50]; [@evu166-B55]\]). However, in some cases a duplicate gene is retained in the population and undergoes either subfunctionalization (where the two duplicates divide the sum of the ancestral role\[s\] between them) or neofunctionalization (where one of the duplicates assumes a new role, independent of the ancestral function \[[@evu166-B13]\]). This latter process of evolving an entirely new function is known to be incredibly rare and there are few conclusive examples of it in the literature ([@evu166-B11]; [@evu166-B67]; [@evu166-B8]).

The venom of advanced snakes has been hypothesized to have originated and diversified through gene duplication ([@evu166-B74]). In particular, it has been suggested that both the origin of venom and the later evolution of novelty in venom have occurred as a result of the duplication of a gene encoding a nonvenom physiological or "body" protein that is subsequently recruited, through gene regulatory changes, into the venom gland, where natural selection can act on randomly occurring mutations to develop and/or increase toxicity ([@evu166-B47]; [@evu166-B22]; [@evu166-B40]; [@evu166-B18]; [@evu166-B3], [@evu166-B4]; [@evu166-B49]; [@evu166-B69]). In short, it has been proposed that snake venom diversifies through repeated gene duplication and neofunctionalization, a somewhat surprising finding given the apparent rarity of both of these events (here we refer to neofunctionalization with respect to the acquisition of novel sites of expression at the level of individual tissues, not the acquisition of novel functions at a molecular level, which is separate from the claims of the duplication/recruitment hypothesis and has been shown to have occurred for only a small number of venom toxins \[[@evu166-B33], [@evu166-B34]; [@evu166-B47]; [@evu166-B35]\], whereas the majority of duplicated toxins retain ancestral bioactivity \[[@evu166-B17]; [@evu166-B73]\]). However, there are currently several gaps in our knowledge of how this remarkable process might take place, including the mechanisms underlying repeated gene duplications and, more importantly, the gene regulatory changes that occur to facilitate "recruitment" into the venom gland. Given that whole-genome duplication is a rare event in vertebrates in general and reptiles in particular ([@evu166-B53]; [@evu166-B48]), it seems likely that the majority of snake venom toxin genes are duplicated through segmental duplication ([@evu166-B30]), where the highly repetitive nature of reptile genomes ([@evu166-B62]; [@evu166-B9]) provides regions of pseudo-homology that facilitate unequal crossing-over during homologous recombination, producing tandemly arranged duplicates. This process requires neither germ-line expression nor the evolution of de novo *cis*-regulatory sequences as does retrotransposition ([@evu166-B76]) and, if repeated so that the resulting pairs or larger clusters of genes were subsequently duplicated in the same manner, a relatively small number of duplication events could give rise to a large number of duplicate genes. Evidence for clusters of multiple snake venom metalloproteinases (SVMP), CRISP (cysteine-rich secretory proteins), and lectin genes in the king cobra genome ([@evu166-B69]) and for PLA~2~ genes in the Okinawan habu (*Protobothrops flavoviridis*) ([@evu166-B31]) would seem to support this hypothesis, although more complete data from these and other snake whole-genome sequencing projects are needed.

Although the above scenario explains the apparent ease with which existing venom toxin genes might be repeatedly duplicated along with their associated *cis*-regulatory architecture, it does nothing to explain how a nonvenom gene might be "recruited" into the venom gland. The paralogous genes produced as a result of gene duplication are 100% identical and, if the entirety of their associated *cis*-regulatory architecture has also been duplicated along with them, they will have identical temporal and spatial expression patterns (i.e., they are functionally redundant; [@evu166-B13]; [@evu166-B46]). Therefore in order to develop a novel site of expression such as in the venom gland, a novel combination of transcriptional regulatory sequences must arise.

Eukaryotic transcription factor binding sites are the result of a trade-off between the specificity offered by longer stretches of DNA and the robustness to mutation offered by shorter sequences and vary in length between 5 and greater than 30 nt, with an average length of 10 nt ([@evu166-B63]). It has been estimated that eukaryotic promoters may contain 10--50 binding sites for 5--15 different transcription factors ([@evu166-B75]). The rarity of gene duplication, coupled with the low likelihood of evolving new combinations of transcription factor binding sites before the duplicated gene is nonfunctionalized by random mutations in coding sequences, should therefore make the process of duplication and recruitment of genes encoding physiological or body proteins into the venom gland exceedingly rare. How then do we reconcile this with the apparent widespread occurrence of this very process in the origin and evolution of snake venom? One possible alternative hypothesis is that many of the genes expressed in snake venom are in fact the result of the duplication of genes that were ancestrally expressed in multiple tissues, including the venom gland. Therefore following duplication these genes evolved through subfunctionalization, with one copy's expression being restricted to the venom gland and the other maintaining the original, multi-tissue expression pattern (possibly with subsequent loss of expression of this paralog in the venom gland). This scenario of duplication and restriction, rather than duplication and recruitment ([fig. 1](#evu166-F1){ref-type="fig"}) is more parsimonious as it requires only the loss of transcription factor binding sites, which may occur by random mutation of single base pairs or larger insertions or deletions (indels) that may delete or disrupt the existing transcriptional regulatory sequences. In order to differentiate between the two hypotheses gene expression data from nonvenom gland tissues in venomous and nonvenomous species are needed, something which has until now been missing. Here, we review the existing evidence for the duplication and recruitment of genes into the venom gland and carry out a comparative transcriptomic survey of gene expression in the venom glands and body tissues of a number of reptile species, including the painted saw-scaled viper (*Echis coloratus*), a medically important viperid with highly toxic venom; the corn snake (*Pantherophis guttatus*) a nonvenomous colubrid that kills its prey through constriction; the rough green snake (*Opheodrys aestivus*) a nonvenomous colubrid that grasps prey and simply swallows it; the royal or ball python (*Python regius*), a nonvenomous pythonid and member of the "primitive" superfamily, Henophidia, and the leopard gecko (*Eublepharis macularius*, Gekkonidae), a lizard that belongs to one of the most basal lineages of squamate reptiles. The phylogenetic position of *Eu. macularius* is particularly important, as it lies outside of the proposed clade of ancestrally venomous reptiles the "Toxicofera" ([@evu166-B68]; [@evu166-B19], [@evu166-B21]; [@evu166-B22]; [@evu166-B18]). Therefore, genes found in the salivary gland of this species can be taken to represent the ancestral squamate expression pattern. We also take advantage of available transcriptomic resources for body tissues in a number of other reptile species, including king cobra (*Ophiophagus hannah*) venom gland, accessory gland and pooled tissues (heart, lung, spleen, brain, testes, gall bladder, pancreas, small intestine, kidney, liver, eye, tongue, and stomach) ([@evu166-B69]), garter snake (*Thamnophis elegans*) liver ([@evu166-B60]) and pooled tissue (brain, gonads, heart, kidney, liver, spleen and blood of males and females) ([@evu166-B61]), Burmese python (*Python molurus bivittatus*) pooled heart and liver ([@evu166-B5]) and corn snake brain ([@evu166-B66]). F[ig]{.smallcaps}. 1.---Restriction and recruitment. Duplicated genes may be either restricted or recruited to the venom gland, with recruitment dependent on the evolution of new combinations of transcription factor binding sites in upstream regulatory regions. Mutation/loss of regulatory regions is indicated with an X.

Materials and Methods
=====================

Total RNA was extracted from the salivary glands, scent glands and skin of two adult corn snakes (*Pa.* *guttatus*), rough green snakes (*O.* *aestivus*), royal pythons (*Py.* *regius*), and leopard geckos (*Eu.* *macularius*). We use the general term "salivary gland" for simplicity, to encompass the oral glands of the leopard gecko, rictal glands of the royal python and Duvernoy's gland of the corn snake and rough green snake and do not imply any homology to mammalian salivary glands. Only a single corn snake skin sample provided RNA of high enough quality for sequencing. RNA samples for painted saw-scaled vipers (*Ec.* *coloratus*) were extracted from the skin, scent glands, kidney and brain of two adult specimens, and liver and ovary samples were extracted from one adult individual. Venom glands from four adult individuals were taken at different time points following venom extraction (16, 24, and 48 h post-milking) in order to capture the full diversity of venom genes. All RNA extractions were carried out using the RNeasy mini kit (Qiagen) with on-column DNase digestion. mRNA was prepared for sequencing using the TruSeq RNA sample preparation kit (Illumina) with a selected fragment size of 200--500 bp and sequenced using 100-bp paired-end reads on the Illumina HiSeq2000 or HiSeq2500 platform. The quality of all raw sequence data was assessed using FastQC ([@evu166-B1]) and reads for each tissue pooled and assembled using Trinity ([@evu166-B26]) (sequence and assembly metrics are provided in [supplementary tables S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) and [S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) online). Venom genes were identified by BLAST ([@evu166-B2]) and maximum-likelihood-based phylogenetic analysis and tissue distribution identified by BLAST-based searches of assembled transcriptomes.

Results and Discussion
======================

We find the hypothesis that snake venom evolves through the duplication of physiological or body genes and subsequent recruitment into the venom gland to be unsupported by the available data. In short, snake venom has not evolved through the recruitment of "body" genes. Indeed for a large number of the gene families claimed to have undergone recruitment we find evidence of a diverse tissue expression pattern, including the salivary gland of nonvenomous reptiles ([fig. 2](#evu166-F2){ref-type="fig"}), demonstrating that if they do encode toxic venom components (Hargreaves et al. submitted), they have not been recruited into the venom gland, but restricted to it. The recently published king cobra genome paper ([@evu166-B69]) also provides evidence for salivary (rictal) gland expression of several venom toxins in the Burmese python, *Python molurus bivittatus*, including 3ftx, cystatin, hyaluronidase, and SVMP ([supplementary table S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) in [@evu166-B69]). F[ig]{.smallcaps}. 2.---Tissue distribution of putative toxin gene families. Many proposed toxin gene families are expressed in a wide range of tissues, including the salivary or venom gland and have therefore been restricted to the venom gland following duplication, not recruited. Tissue abbreviations: Sal, salivary gland; VG, venom gland; Bra, brain; Liv, liver; K, kidney; O, ovary; P, pooled tissue (see text for details). Species abbreviations: Ema, leopard gecko (*Eublepharis macularius*); Pre, royal python (*Python regius*); Oae, rough green snake (*Opheodrys aestivus*); Pgu, corn snake (*Pantherophis guttatus*); Eco, painted saw-scaled viper (*Echis coloratus*); Oha, king cobra (*Ophiophagus hannah*); Tel, garter snake (*Thamnophis elegans*).

Therefore although some venom toxin genes have in the past been suggested to represent ancestral salivary proteins (notably CRISPs and Kallikrein-like serine proteases \[[@evu166-B17]; [@evu166-B65]), our analysis in fact shows that the majority of snake venom toxins are likely derived from pre-existing salivary proteins. Far from being an incredibly complex cocktail of proteins ([@evu166-B33]; [@evu166-B70]; [@evu166-B14]; [@evu166-B4]) recruited from multiple body tissues ([@evu166-B17]; [@evu166-B22]; [@evu166-B73]; [@evu166-B4]), snake venom should instead be considered to be simply a modified form of saliva, where a relatively small number of gene families (typically 6--14) have expanded through gene duplication, often in a lineage-specific manner ([@evu166-B38]; [@evu166-B71]; [@evu166-B12]; [@evu166-B69]).

The study cited most frequently in support of the duplication and recruitment hypothesis is that of [@evu166-B17] (see, e.g., [@evu166-B73]; [@evu166-B32]; [@evu166-B3], [@evu166-B4]) and we therefore refer to this hypothesis as the "genome to venome hypothesis." In his study, Fry concluded that the evolution of snake venom was characterized by at least 24 recruitment events ([@evu166-B17]). However, this analysis was based on assumptions that snake venom toxin sequences derived primarily from expressed sequence tag-based studies of only the venom gland could be considered to be venom gland-specific and that if they were related to a gene known to be expressed in the pancreas (or another tissue) of human or other species they must therefore represent a recruitment event. It is obviously possible that the same gene may be expressed in the pancreas (or other tissue) of the snake as well and that the lack of data for these nonvenom gland tissues is obscuring the true extent of their expression. It must be considered therefore that for the majority of genes Fry does not actually demonstrate any evidence for gene duplication and subsequent recruitment.

Only four examples in Fry's study include both "body" and venom gland sequences from venomous snakes and therefore only these four possibly show any evidence in support of gene duplication and recruitment into the venom gland: crotamine, complement C3, natriuretic peptide, and Group IB phospholipase A~2~ ([@evu166-B17]). Of these, the South American rattlesnake (*Crotalus durissus terrificus*) *crotamine-*like sequence labeled as "Pancreas" (accession number Q6HAA2) was in fact originally described to be highly expressed in pancreas, heart, liver, brain, and kidneys (i.e., all tissues examined) with "scarce" but detectable expression in the venom gland ([@evu166-B57]). Our transcriptomic data show that the toxic form of *crotamine* is derived from the duplication of a nontoxic *β-defensin*-like gene with a wider expression pattern that included the salivary/venom gland ([fig. 2](#evu166-F2){ref-type="fig"}) and that the toxic duplicate has been restricted, not recruited, to the venom gland. For *complement C3*, Fry's analysis ([@evu166-B17]) utilized Indian cobra (*Naja naja*) sequences from liver (accession number Q01833) ([@evu166-B16]) and venom gland (accession number Q91132) ([@evu166-B15]). However, both sequences were in fact isolated from what the authors refer to as *Naja naja kaouthia*, a synonym for the monocled cobra, *N.* *kaouthia*. This inaccuracy notwithstanding, Fry's analysis does suggest that there has been a duplication of a *complement C3* gene to give rise to a new copy (often referred to as "cobra venom factor," more rightly called *complement C3b*) although the lack of data for other body tissues should have precluded claims of recruitment. Analysis of our transcriptome data in fact reveals that *complement C3* is expressed in a diverse array of body tissues in multiple species, including the salivary gland of nonvenomous reptiles ([figs. 2](#evu166-F2){ref-type="fig"} and [3](#evu166-F3){ref-type="fig"}) and that a paralogous copy of this gene has therefore been restricted to the venom gland following duplication. Although *Bothrops jararaca* does appear to possess at least two distinct forms of natriuretic peptide ([@evu166-B29]; [@evu166-B28]), the situation may also be more complex than that originally presented, as the sequence labeled as "Brain" by Fry (accession Q9PW56, identical to AAD51326) in fact shows a wider expression pattern that includes brain, spleen, venom gland and, possibly, pancreas ([@evu166-B51]; [@evu166-B29]; [@evu166-B28]). We find few natriuretic peptides in our data set ([fig. 2](#evu166-F2){ref-type="fig"}), and the low number of these sequences previously characterized would suggest that they play little role in the venom of snakes other than *Bothrops* spp., where they appear to have undergone duplication and subfunctionalization. Finally, Fry used *Group IB phospholipase A~2~* (*PLA~2~ IB*) sequences from the pancreas of the banded sea krait (*Laticauda semifasciata*, accession Q8JFG2) and the venom gland of the Australian coastal taipan (*Oxyuranus scutellatus*, accession P00615) to support recruitment. We find *PLA~2~ IB* genes to be expressed in several body tissues, including the leopard gecko salivary gland ([fig. 2](#evu166-F2){ref-type="fig"} and [supplementary fig. S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) online), suggesting a wider ancestral expression pattern than previously claimed. F[ig]{.smallcaps}. 3.---Maximum-likelihood tree of *complement C3* genes. *complement C3* genes are expressed in a diversity of tissues, including venom and salivary glands. Following a gene duplication event (marked with \*, shaded dark gray) one paralog has been restricted to the venom gland in the king cobra (*Ophiophagus hannah*) and the monocled cobra (*Naja kaouthia*). The two distinct king cobra sequences most likely represent geographic variation between Indonesian and Chinese populations. An additional gene duplication event appears to have occurred in the *Austrelaps superbus* lineage (marked with +, shaded light gray). Lineages for which body (nonvenom gland) sequences are available are colored blue and bootstrap values for 500 replicates are shown above branches.

It has recently been suggested that there has been a duplication of *nerve growth factor* (*ngf*) genes in some snake species ([@evu166-B64]), although the presence of additional copies of *ngf* in certain species of cobra has been known for some time ([@evu166-B43]; [@evu166-B36]). Our data show that the nontoxic form of *ngf* (which we call *ngfa*) is expressed in a diversity of tissues, including the salivary glands of nonvenomous reptiles ([fig. 2](#evu166-F2){ref-type="fig"} and [supplementary fig. S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) online). The putatively toxic version (*ngfb*) has therefore also been restricted to the venom gland following duplication.

Both coagulation *factor V* and *factor X* have been suggested to have undergone gene duplication in Australian elapids such as *Tropidechis carinatus* and *Pseudonaja textilis* with subsequent recruitment of a gene normally expressed in the liver into the venom gland ([@evu166-B42]; [@evu166-B58]; [@evu166-B40]; [@evu166-B39]). However, these studies do not appear to have investigated body tissues other than liver and venom gland ([@evu166-B42]) and so cannot be relied upon to demonstrate the full extent of ancestral gene expression. Our analysis in fact shows *factor V* to be expressed in multiple tissues, including rough green snake scent gland, King cobra accessory gland, *Ec.* *coloratus* scent gland, kidney, brain, ovary and skin and the scent gland, skin and salivary gland of the leopard gecko ([fig. 2](#evu166-F2){ref-type="fig"} and [supplementary fig. S3](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) online). *Factor X* is also expressed in multiple tissues ([fig. 2](#evu166-F2){ref-type="fig"} and [supplementary fig. S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1), [Supplementary Material](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) online), including the salivary or venom glands of leopard gecko, royal python, rough green snake, corn snake, and *Ec.* *coloratus*. In both cases therefore a gene with a wide expression pattern that included the salivary or venom gland has undergone duplication and restriction. The known increased expression of a *factor X* paralog following an insertion in the promoter region ([@evu166-B58]; [@evu166-B40]; [@evu166-B39]; [@evu166-B27]) and the increased expression of *crotamine* in the venom gland following duplication ([@evu166-B56], [@evu166-B57]) suggest that a possible route for pre-existing salivary proteins to become venom toxins may simply be an elevated expression level, where initial toxicity is dosage-dependent.

Interestingly, some of the key papers cited in support of the genome to venome hypothesis in fact discuss the recruitment of genes into the venom proteome, *not* the venom gland itself ([@evu166-B25]; [@evu166-B17]) with such claims only becoming more common in the literature some time later (see, e.g., [@evu166-B20]; [@evu166-B10]; [@evu166-B4]). Added to the fact that these papers show no evidence for duplication and recruitment of "body" genes it must be concluded that not only is this hypothesis not supported by our newly available data, but that it was never supported. It appears therefore that a misunderstanding of the scope of the claims of these earlier studies together with the known role for gene duplication in the *diversification* of snake venom ([@evu166-B37]) is responsible for the development and propagation of the attractive, but ultimately unsupported, duplication and venom gland recruitment hypothesis. In order to fully understand the evolution of snake venom, more transcriptomic data are needed from a much greater variety of species for a much greater number of body tissues, ideally at a wider diversity of stages of venom synthesis and with consideration of sex, ontogeny, shedding and reproductive cycles and the large-scale effects on metabolism of intermittent feeding on large prey ([@evu166-B72]; [@evu166-B6]). Even so, it will be difficult to fully account for all possible spatial and temporal influences on gene expression, and the default assumption for the fate of duplicate genes should perhaps therefore be subfunctionalization, not neofunctionalization.

Finally, our findings highlight the problem of "just-so stories" ([@evu166-B59]) in evolutionary biology, especially when they reach the point of being considered established fact. The genome-to-venome hypothesis has been widely and unquestioningly cited and treated neither as a hypothesis to be tested and refuted ([@evu166-B54]) nor as a scientific research program to provide predictions to be investigated ([@evu166-B41]). Although the role of gene duplication should rightly be considered as part of the core of the snake venom evolution research program, we propose that many associated hypotheses are in need of a greater degree of scrutiny than they have hitherto received. Only after such scrutiny will we truly understand "How The Snake Got His Venom."
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[Supplementary tables S1](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) and [S2](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) and [figures S1--S4](http://gbe.oxfordjournals.org/lookup/suppl/doi:10.1093/gbe/evu166/-/DC1) are available at *Genome Biology and Evolution* online (<http://www.gbe.oxfordjournals.org/>).
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